Vol. 63, No. 10 (2015)
Chem. Pharm. Bull.
823
(400MHz, CDCl3) δ: 6.24–6.25 (2H, m), 6.77–6.78 (1H, 107.0, 120.4, 127.0, 127.5, 128.5, 129.0, 132.7, 137.5, 141.1ppm;
m), 7.78 (1H, s), 7.86 (1H, s), 9.26 (1H, brs) ppm; 13C-NMR IR (KBr) ν 3107, 3063, 2930, 1577, 1496, 1487, 1455, 1281,
(100MHz, CDCl3) δ: 98.1, 108.8, 116.9, 121.9, 126.0, 1251, 1112, 1068, 996, 756, 714cm−1; HR-MS (FAB) Calcd for
133.9ppm; IR (KBr) ν 3151, 1589, 1499, 1299, 1050, 1028, 912, C14H14N3 m/z 224.1188 [M+H]+, Found 224.1182.
743 cm−1; MS (MALDI-TOF) Calcd for C6H7N4 m/z 135.07;
[M+H]+, Found: 133.9 (84), 134.9 (100).
1-(1-Benzyl-1H-pyrrol-2-yl)-1H-imidazole (5ad) 1H-NMR
(400MHz, CDCl3) δ: 4.79 (2H, s), 6.19–6.20 (2H, m), 6.71
1-(5-Ethyl-1H-pyrrol-2-yl)-1H-1,2,3-triazole (5fa) 1H-NMR (1H, t, J=2.4Hz), 6.82 (1H, s), 6.87–6.90 (2H, m), 7.06 (1H,
(400MHz, CDCl3) δ: 1.25 (3H, t, J=7.2Hz), 2.65 (2H, q, s), 7.20–7.29 (3H, m), 7.37 (1H, s) ppm; 13C-NMR (100MHz,
J=7.2Hz), 5.91 (1H, s), 6.12 (1H, t, J=3.0Hz), 7.73 (1H, s), 7.81 CDCl3) δ: 49.5, 105.7, 107.3, 120.8, 121.7, 125.2, 126.3, 127.8,
(1H, s), 9.30 (1H, brs) ppm; 13C-NMR (100MHz, CDCl3) δ: 128.7, 129.2, 137.0, 139.1ppm; IR (KBr) ν 3110, 2924, 1708,
13.4, 20.7, 98.0, 104.6, 121.6, 124.4, 133.5, 133.7ppm; IR (KBr) 1574, 1490, 1348, 1311, 1235, 1060, 819, 720, 660cm−1;
ν 3152, 2969, 1601, 1597, 1223, 1050, 1018, 776cm−1; MS HR-MS (FAB) Calcd for C14H14N3 m/z 224.1188 [M+H]+,
(MALDI-TOF) Calcd for C8H11N4 m/z 163.10 [M+H]+, Found Found 224.1182.
162.18 (92), 163.19 (100).
1-(1H-Pyrrol-2-yl)-1H-benzo[d][1,2,3]triazole (5ee)
A
1-(4-Ethyl-3,5-dimethyl-1H-pyrrol-2-yl)-1H-1,2,3-triazole white solid; mp 110–113°C; 1H-NMR (400MHz, CDCl3)
(5ga) 1H-NMR (400MHz, CDCl3) δ: 1.07 (3H, t J=7.6Hz), δ: 6.36–6.38 (1H, m), 6.44–6.48 (1H, m), 6.86–6.88 (1H,
2.01 (3H, s), 2.19 (3H, s), 2.41 (2H, q, J=1.7Hz), 7.75–7.77 (2H, m), 7.42 (1H, t, J=8.0Hz), 7.56 (1H, t, J=8.0Hz), 7.73 (1H,
m), 8.37 (1H, brs) ppm; 13C-NMR (100MHz, CDCl3) δ: 8.7, d, J=8.3Hz), 8.09 (1H, d, J=8.3Hz), 9.17 (1H, brs) ppm;
10.8, 15.5, 17.5, 109.4, 119.7, 121.2, 122.0, 123.7, 133.4ppm; IR 13C-NMR (100MHz, CDCl3) δ: 99.4, 109.0, 110.5, 116.8,
(KBr) ν 3195, 2961, 1619, 1542, 1450, 1384, 1284, 1035, 913, 120.0, 124.6, 124.9, 128.5, 131.9, 145.6ppm; IR (KBr) ν 3202,
782cm−1; MS (MALDI-TOF) Calcd for C10H15N4 m/z 191.13 2571, 1714, 1583, 1442, 1216, 1085, 1027, 938, 744, 658cm−1;
[M+H]+, Found 190.15 (64), 191.16 (100).
HR-MS (FAB) Calcd for C10H9N4 m/z 185.0826 [M+H]+,
1-(3,5-Dimethyl-1H-pyrrol-2-yl)-1H-1,2,3-triazole (5ha) Found 185.0822.
1H-NMR (400MHz, CDCl3) δ: 2.06 (3H, s), 2.25 (3H, s),
5.77 (1H, d, J=2.9Hz), 7.765 (1H, s), 7.77 (1H, s), 8.56 (1H,
Acknowledgments This work was partially supported by
brs) ppm; 13C-NMR (100MHz, CDCl3) δ: 10.5, 12.8, 108.42, Grants-in-Aid for Scientific Research (A) from the Japan So-
108.44, 110.3, 123.6, 126.4, 133.4ppm; IR (KBr) ν 3148, 2925, ciety for the Promotion of Science (JSPS), a Grant-in-Aid for
1618, 1538, 1326, 1224, 1094, 953, 793cm−1; MS (MALDI- Scientific Research on Innovative Areas “Advanced Molecular
TOF) Calcd for C8H11N4 m/z 163.10 [M+H]+, Found 162.13 Transformation by Organocatalysts” from the Ministry of
(56), 163.14 (100).
1-(1H-1,2,3-Triazole-1-yl)-4,5,6,7-tetrahydro-2H-isoin- of Japan. K. M. also acknowledges support from the Grant-in-
dole (5ia)
white solid; mp 127–129°C; 1H-NMR Aid for Young Scientists (B) from the JSPS.
Education, Culture, Sports, Science and Technology (MEXT)
A
(400MHz, CDCl3) δ: 1.70–1.81 (4H, m), 2.58–2.61 (4H, m),
6.47 (1H, d, J=2.5Hz), 7.77 (1H, s), 7.81 (1H, s), 8.86 (1H, brs)
Conflict of Interest The authors declare no conflict of
ppm; 13C-NMR (100MHz, CDCl3) δ: 21.5, 22.0, 23.3, 23.4, interest.
109.6, 111.6, 120.6, 121.8, 133.7ppm; IR (KBr) ν 3148, 2925,
1714, 1533, 1325, 1230, 1034, 767, 592cm−1; MS (MALDI-
References and Notes
TOF) Calcd for C10H13N4 m/z 189.11 [M+H]+, Found 188.05
(40), 189.06 (100).
1) “Comprehensive Heterocyclic Chemistry II,” Vol. 2, ed. by Fan W.
Q., Katritzky A. R., Rees C. W., Scriven E. F. V., Pergamon Press,
3-Methyl-2-[1,2,3]triazol-1-yl-1H-indole (5ja)59) 1H-NMR
(400MHz, CDCl3) δ: 2.34 (3H, s), 7.14 (1H, dd, J=8.0, 1.0Hz),
7.25 (1H, dd, J=8.0, 1.0Hz), 7.37 (1H, d, J=8.0Hz), 7.56 (1H,
d, J=8.0Hz), 7.83 (1H, s), 7.97 (1H, s), 9.44 (1H, brs) ppm;
13C-NMR (100MHz, CDCl3) δ: 8.4, 101.9, 111.4, 119.3, 120.3,
123.6, 123.7, 127.4, 127.8, 133.5, 133.9ppm.
1-(1-Benzyl-1H-pyrrol-2-yl)-4-butyl-1H-1,2,3-triazole
(5ab) A brown solid; mp 73–77°C; 1H-NMR (400MHz,
CDCl3) δ: 0.95 (3H, t, J=7.6Hz), 1.31–1.41 (2H, m), 1.59–1.67
(2H, m), 2.71 (2H, t, J=7.8Hz), 5.01 (2H, s), 6.25 (1H, t,
J=3.7Hz), 6.29–6.31 (1H, m), 6.78–6.79 (1H, m), 6.94–6.97
(2H, m), 7.15 (1H, s), 7.24–7.29 (3H, m) ppm; 13C-NMR
(100MHz, CDCl3) δ: 13.8, 22.1, 25.0, 31.3, 50.4, 105.4, 107.3,
121.6, 123.9, 125.3, 126.9, 127.7, 128.6, 136.8, 147.6ppm; IR
(KBr) ν 3111, 2956, 2859, 1950, 1576, 1496, 1453, 1274, 1230,
1274, 1070, 1007, 913, 722cm−1; MS (MALDI-TOF) Calcd for
C17H21N4 m/z 281.18 [M+H]+, Found 281.13 (100), 282.13 (20).
1-(1-Benzyl-1H-pyrrol-2-yl)-1H-pyrazole (5ac) 1H-NMR
(400MHz, CDCl3) δ: 4.96 (2H, s), 6.16 (1H, t, J=3.4Hz),
6.19–6.21 (1H, m), 6.28 (1H, s), 6.64 (1H, s), 6.95 (2H, d,
J=8.3Hz), 7.18–7.23 (3H, m), 7.36 (1H, d, J=2.4Hz), 7.69 (1H,
s) ppm; 13C-NMR (100MHz, CDCl3) δ: 50.0, 104.4, 106.1,